Finding. Neuropsychiatric long COVID has a serum look: triacylglycerides and acylcarnitines move, and those moves track how depressed and exhausted people feel and how thick several cortical territories are. The authors call it a lipid-metabolism phenotype that may mark a mitochondrial energy problem. It may. It is still a blood-metabolome correlation.
Why this paper matters
Long COVID cognition is being told as neuroinflammation plus structural MRI. A peripheral metabolome that lines up with both symptoms and thickness gives the field a blood handle. Acylcarnitines are why a mitochondrial desk should keep the paper, with the inference labeled as inference.
What they actually measured
Serum metabolomes, cases versus controls, associations with depression/fatigue and cortical thickness. No mitochondrial enzymology.
How to read the score
Mid-to-high sixties. Resource plus a fair acylcarnitine hook. Score 67. Confidence is medium for the metabolome difference, low for organelle causation.
What to do with it
If you study long COVID or serum acylcarnitines, pull the species list and the thickness maps. Do not tell patients their mitochondria are proven broken from this brief. The directional implication is that a lipid/acylcarnitine peripheral signature accompanies neuropsychiatric long COVID and covaries with mood, fatigue, and cortex.